glp 1 in canada 3 million Canadians take GLP-1 drugs, reshape habits: survey New study ties weight-loss drugs

Reflux is when stomach acid comes back up

At Flawless MedSpa & The Beverly Hills MedSpa, we understand that achieving and maintaining a healthy weight is a multifaceted journey that often requires a personalized approach

Reduced-Frequency GLP1 Therapy Maintains Weight, Body Composition, and Metabolic Syndrome Improvements: A Case Series

Orforglipron, an oral small-molecule GLP-1 receptor agonist, for the treatment of obesity in people with type 2 diabetes (ATTAIN-2): a phase 3, double-blind, randomised, multicentre, placebo-controlled trial

Efficacy and safety of lixisenatide once daily versus exenatide twice daily in type 2 diabetes inadequately controlled on metformin: a 24-week, randomized, open-label, active-controlled study (GetGoal-X)

Injectable GLP-1 drugs will continue to be developed, with Novo Nordisk advancing multiple candidates